Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
Penther D, Viailly PJ, Latour S, Etancelin P, Bohers E, Vellemans H, Camus V, Menard AL, Coutant S, Lanic H, Lemasle E, Drieux F, Veresezan L, Ruminy P, Raimbault A, Soulier J, Frebourg T, Tilly H, Jardin F. Penther D, et al. Among authors: menard al. Genes Chromosomes Cancer. 2019 Aug;58(8):595-601. doi: 10.1002/gcc.22743. Epub 2019 Mar 27. Genes Chromosomes Cancer. 2019. PMID: 30779244 Free PMC article.
Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study.
Stamatoullas A, Rezine I, Mareschal S, Ménard AL, Lanic H, David M, Daliphard S, Penther D, Lemasle E, Cassuto O, Lenain P, Contentin N, Lepretre S, Jardin F, Bastard C, Tilly H. Stamatoullas A, et al. Among authors: menard al. Leuk Lymphoma. 2016;57(6):1491-3. doi: 10.3109/10428194.2015.1101096. Epub 2015 Nov 16. Leuk Lymphoma. 2016. PMID: 26430832 No abstract available.
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Bohers E, Viailly PJ, Becker S, Marchand V, Ruminy P, Maingonnat C, Bertrand P, Etancelin P, Picquenot JM, Camus V, Menard AL, Lemasle E, Contentin N, Leprêtre S, Lenain P, Stamatoullas A, Lanic H, Libraire J, Vaudaux S, Pepin LF, Vera P, Tilly H, Jardin F. Bohers E, et al. Among authors: menard al. Blood Cancer J. 2018 Aug 1;8(8):74. doi: 10.1038/s41408-018-0111-6. Blood Cancer J. 2018. PMID: 30069017 Free PMC article.
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.
Camus V, Viennot M, Lequesne J, Viailly PJ, Bohers E, Bessi L, Marcq B, Etancelin P, Dubois S, Picquenot JM, Veresezan EL, Cornic M, Burel L, Loret J, Becker S, Decazes P, Lenain P, Lepretre S, Lemasle E, Lanic H, Ménard AL, Contentin N, Tilly H, Stamatoullas A, Jardin F. Camus V, et al. Among authors: menard al. Haematologica. 2021 Jan 1;106(1):154-162. doi: 10.3324/haematol.2019.237719. Haematologica. 2021. PMID: 32079702 Free PMC article.
Outcomes after intensive care unit admission in newly diagnosed diffuse large B-cell lymphoma patients: A real-life study.
Zduniak A, Mihailescu SD, Lequesne J, Lenain P, Contentin N, Pepin LF, Ménard AL, Leprêtre S, Lemasle E, Lanic H, Stamatoullas-Bastard A, Tilly H, Tamion F, Jardin F, Camus V. Zduniak A, et al. Among authors: menard al. Eur J Haematol. 2021 Jun;106(6):788-799. doi: 10.1111/ejh.13606. Epub 2021 Mar 5. Eur J Haematol. 2021. PMID: 33624346 Clinical Trial.
Prognostic relevance of lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience.
Pénichoux J, Dubois S, Krzisch D, Menard AL, Lanic H, Camus V, Lemasle E, Leprêtre S, Lenain P, Contentin N, Daliphard S, Buchonnet G, Penther D, Bastard C, Tilly H, Jardin F, Stamatoullas A. Pénichoux J, et al. Among authors: menard al. Leuk Lymphoma. 2021 Sep;62(9):2272-2275. doi: 10.1080/10428194.2021.1907381. Epub 2021 Apr 2. Leuk Lymphoma. 2021. PMID: 33797310 No abstract available.
Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas.
Candon S, Lemee V, Leveque E, Etancelin P, Paquin C, Carette M, Contentin N, Bobee V, Alani M, Cardinael N, Lepretre S, Camus V, Bouclet F, Boulet E, Menard AL, Lanic H, Stamatoullas A, Lemasle E, Pepin LF, Richard D, Dubois S, Tilly H, Dalleac A, Plantier JC, Etienne M, Jardin F. Candon S, et al. Among authors: menard al. Haematologica. 2022 Mar 1;107(3):755-758. doi: 10.3324/haematol.2021.280139. Haematologica. 2022. PMID: 34854280 Free PMC article. No abstract available.
Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first-line treatment for patients with diffuse large B-cell lymphoma.
Pénichoux J, Rio J, Kammoun L, Vermeulin T, Pepin LF, Camus V, Dubois S, Bouclet F, Alani M, Contentin N, Leprêtre S, Stamatoullas A, Lanic H, Lemasle E, Ménard AL, Lenain P, Gilles-Baray M, Georgescu D, Clatot F, Tilly H, Jardin F. Pénichoux J, et al. Among authors: menard al. Eur J Haematol. 2022 Jul;109(1):41-49. doi: 10.1111/ejh.13767. Epub 2022 Mar 21. Eur J Haematol. 2022. PMID: 35285085 Free PMC article.
49 results